{"id":"W4311354885","doi":"10.2147/ppa.s379065","title":"Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)","year":2022,"lang":"en","type":"article","venue":"Patient Preference and Adherence","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences North; University Health Network; Ottawa Hospital; Vancouver Infectious Diseases Centre; Centre hospitalier de l'Université Laval; University of British Columbia; Toronto General Hospital; University of Toronto; Centre Hospitalier de l’Université de Montréal; University of Regina; McGill University; McGill University Health Centre; Canadian Institutes of Health Research","funders":"Canadian Institutes of Health Research; ViiV Healthcare","keywords":"Dolutegravir; Medicine; Lamivudine; Abacavir; Randomized controlled trial; Internal medicine; Randomization; Zidovudine; Tenofovir alafenamide; Viral load; Human immunodeficiency virus (HIV); Antiretroviral therapy; Virology; Viral disease; Virus","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009292614,0.0006588578,0.001608865,0.0003622305,0.0004641941,0.0002713295,0.0006829928,0.00008155963,0.001565063],"category_scores_gemma":[0.0005273338,0.0004017734,0.0001020658,0.001123755,0.0002232706,0.0006824635,0.001031428,0.001161285,0.0000481733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000216687,"about_ca_system_score_gemma":0.0005266292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001674114,"about_ca_topic_score_gemma":0.005553615,"domain_scores_codex":[0.9947212,0.0008048314,0.0008959145,0.001370908,0.001236007,0.0009711698],"domain_scores_gemma":[0.9974191,0.0006046199,0.0003713139,0.0006348773,0.000370232,0.0005998583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1579931,0.0120804,0.8053563,0.000124466,0.0003601679,0.0003665977,0.01552662,0.00001450131,0.0003329631,0.00005310051,0.00009975117,0.007692007],"study_design_scores_gemma":[0.3128809,0.1827343,0.4716544,0.001805927,0.0004239278,0.00009526629,0.02713185,0.001990364,0.0001082386,0.00007457273,0.00004352358,0.001056654],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849804,0.00007299904,0.0006404947,0.0002582484,0.0000318989,0.01212106,0.0001403531,0.0000857732,0.001668736],"genre_scores_gemma":[0.9827756,0.00002380001,0.0015276,0.0002728957,0.00001273685,0.01148854,0.00006269199,0.00005075191,0.003785373],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3337018,"threshold_uncertainty_score":0.9998434,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04360992984571242,"score_gpt":0.3438223160218185,"score_spread":0.3002123861761061,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}